Demonstrating value amid pricing pressures is believed to be the most critical strategic issue facing the life sciences industries. Understanding the global market access and reimbursement needs of key markets is the first step in developing a plan to demonstrate the value of products. But manufacturers of drugs, devices, or diagnostic tests fail to adequately understand and address the market access and reimbursement needs of the marketplace. As a result, they fail to leverage the value and optimize the commercial success of their products. More information and online registration is available here.